化合物简介
MK 1775 is used in biological studies for the abrogation of G2/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma.
基本信息
中文名称
2-烯丙基-1-(6-(2-羟基丙烷-2-基)吡啶-2-基)-6-(4-(4-甲基哌嗪-1-基)苯基氨基)-1H-吡唑并[3,4-d]嘧啶-3(2H)-酮
英文名称
1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one
中文别名
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基)-6-(4-(4-甲基哌嗪-1-基)苯基氨基)-1H-吡唑并[3,4-D]嘧啶-3(2H)-酮
英文别名
2-allyl-1,8-dimethoxyanthracene-9,10-dione、2-allyl-1,8-dimethoxy-9,10-anthraquinone、2-allyl-1-[6-(1-hydroxy-1-methylethyl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one、9,10-Anthracenedione,1,8-dimethoxy-2-(2-propenyl)
CAS号
955365-80-7
分子式
C27H32N8O2
分子量
500.595
精确质量
500.265
PSA
104.34
LOGP
2.9619
编号系统
UNII
K2T6HJX3I3
物化性质
密度
1.293 g/cm3
沸点
723.804ºC at 760 mmHg
闪点
391.543ºC
合成路线